More than 100 days into President Donald Trump’s second term, the administration has fallen into a pattern. Trump releases an ...

We believe that Merck KGaA enjoys a narrow moat, driven by intangible assets and switching costs which are prevalent in its Life Science and Electronics businesses. A few acquisitions to fill gaps in ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

Morristown-based Sanofi will be the latest U.S drugmaker to inject billions of dollars into domestic operations and American manufacturing.

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...

Is there anyone who thinks prescription drug prices in America are about right? President Trump has elevated an issue ...

It's no secret that brand-name drugs in the U.S. are much more expensive than they are abroad. In the spirit of fairness, the ...

The government held a consultative meeting with private sector stakeholders Thursday to promote the use of artificial ...

Denmark’s economic growth, which was driven by what economists described as an “exceptional surge” in pharmaceutical exports, ...

Amid rising prescription drug prices, local pharmacists are questioning federal efforts—like Donald Trump's executive order to lower costs—warning it could have unintended consequences.

Gov. Gavin Newsom will seek to regulate prescription drug intermediaries, eight months after vetoing a similar bill.